# Elements of Adaptive Immunity in Epithelial Ovarian Cancer

> **NCT07528911** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 687 (actual)

## Conditions studied

- Epithelial High Grade Serous Ovarian Cancer

## Interventions

- **OTHER:** Assessment of elements of adaptive immunity in tumor biopsies

## Key facts

- **NCT ID:** NCT07528911
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-06-22
- **Target enrollment:** 687 (ACTUAL)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07528911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07528911, "Elements of Adaptive Immunity in Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07528911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
